<DOC>
	<DOCNO>NCT00314132</DOCNO>
	<brief_summary>The purpose study ass whether ChimeriVax™ JE vaccine ( new vaccine use vaccination Japanese encephalitis ) safe well tolerate compare placebo ( dummy ) vaccination .</brief_summary>
	<brief_title>Safety Study ChimeriVax™-JE Vaccine Prevent Japanese Encephalitis .</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Informed consent obtain subject . Aged 18 year screen . In good general health Subject available study duration For female subject ( child bear potential ) negative pregnancy test Screening Day 0 . A history vaccination infection JE . Known suspect immunodeficiency , use immunosuppressive antineoplastic drug . History thymoma , thymic surgery ( removal ) myasthenia gravis . Clinically significant abnormality laboratory assessment Anaphylaxis serious adverse reaction characterise urticaria angioedema food , Hymenoptera ( bee family ) sting , drug include vaccine ) . Transfusion blood treatment blood product , include intramuscular intravenous serum globulin within six month Screening Visit Day 30 . Administration another vaccine antiviral within 30 day precede Screening visit Day 30 . Physical examination indicate clinically significant medical condition . Oral temperature &gt; 38°C ( 100.4°F ) acute illness within 3 day prior inoculation . Intention travel area extend period may affect subject ability attend clinic visit prior study visit Day 30 . Seropositive hepatitis C virus ( HCV ) HIV positive Hepatitis B Surface Antigen . Lactation intend pregnancy female subject . Excessive alcohol consumption , drug abuse , significant psychiatric illness . A know suspected physiological structural condition compromise integrity bloodbrain barrier ( e.g . cerebrovascular disease , multiple sclerosis , trauma , infection , inflammation brain meninges ) . Participation another clinical study within 30 day screen visit study . Employee study site , Sponsor Clinical Research Organization ( CRO ) involve management study . Any reason , investigator 's opinion , make subject unsuitable participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Japanese Encephalitis</keyword>
	<keyword>Encephalitis virus</keyword>
	<keyword>ChimeriVax™-JE Vaccine</keyword>
</DOC>